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I have had a great fascination for the bones, joints and muscles of the human body since long 
before I started my medical education, and naturally developed an attraction towards 
orthopedics once I started university. That is why contacting the orthopedic department at the 
university hospital was the obvious choice for me when it came to choosing a subject for my 
thesis. I contacted Khaled Meknas, MD, PhD who agreed to be my supervisor. He presented 
the subject, and I agreed to take it on. The objective of the project is to assess the outcomes of 
stemless hemiarthroplasty in patients with osteoarthritis of the glenohumeral joint operated at 
the University Hospital of North Norway.  
I would like to thank Khaled Meknas for a great oppurtunity and patience during the 
work process, and for providing good advice and relevant literature to the thesis. Meknas also 
spent three days in the outpatient clinic together with the author to conduct the follow up 
sessions. Thank you for brilliant supervision! I would also like to offer my thanks to Hilde 
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Background: Osteoarthritis is the most common form of arthritis and end stage treatment 
includes arthroplasty. The gold standard for treatment of shoulder osteoarthritis is total 
arthroplasty with stemmed prosthesis. The trend surrounding shoulder arthroplasty focuses on 
reducing stem-related complication, but mid- to long-term studies on stemless 
hemiarthroplasty are needed to evaluate durability. Our hypothesis was that stemless 
hemiarthroplasty is a good and reliable alternative for treatment of shoulder OA. 
 
Method: 21 shoulders in 17 patients with glenohumeral osteoarthritis were treated with 
Eclipse stemless HSA from 2010 to 2016, and followed for four to eleven years. Functional 
outcomes were evaluated using VAS, ASES and CS, while superior caput migration, degree 
of glenoid erosion and radiolucency was assessed on radiographs.  
 
Results: At last follow up time, there was significant improvement of VAS, ASES and CS 
from (7.5) to (1.8) p< 0.05, (36.4) to (84.1) p<0.05, and (33.5) to (79.6) p<0.05 respectively. 
In addition, there was no clinically significant radiological changes. 
 
Conclusion: In this retrospective study, the clinical assessments revealed significant 
improvements in the VAS, ASES and CS seven years after intervention. There were minimal 


















OA – Osteoarthritis  
RA – Rheumatoid arthritis 
HSA – Hemiarthroplasty of the shoulder 
TSA – Total shoulder arthroplasty  
UNN – University Hospital of North Norway  
ASES – American Shoulder and Elbow Surgeons 
CS – Constant-Murley score 
ADL – Activities of daily living 
ROM – Range of motion 



















1.1 Glenohumeral osteoarthritis  
1.1.1 Definition and clinical picture  
Arthritis is commonly used term to describe any disease affecting the joints of the body. 
Osteoarthritis (OA) and rheumatoid arthritis (RA) are the two most common forms of 
arthritis. While RA is an autoimmune disease OA is a degenerative one and does not involve 
the immune system. OA is a disease that can affect any synovial joint of the body. A synovial 
joint is an organ consisting of joint cartilage, subchondral bone and a joint capsule, covered 
by synovial membrane on the inside and reinforced by ligaments on the outside (1). OA is 
defined as a degenerative, non-inflammatory joint disease characterized by degeneration of 
articular cartilage and subchondral bone, with narrowing of the joint space as a result. It is a 
gradual and progressive process that through mechanical and biochemical breakdown of the 
joint components causes loss of joint function, pain and instability (2). Other types of arthritis 
include gout, lupus, fibromyalgia and septic arthritis (3). 
The glenohumeral joint OA causes pain and disability. The diagnosis involves a certain set of 
symptoms, physical examination findings and radiological changes to the bone; the humeral 
head, the glenoid or both. Initially patients often suffer from activity related pain that is 
localized deep in the joint, mostly posteriorly. Progression of the disease makes nocturnal 
pain and resting pain more common, and sleep disturbance is reported more frequently (4;5). 
In advanced stages of OA physical examination demonstrates a loss of active and passive 
range of motion in the shoulder joint with bony crepitus i.e. significant loss of function (5). 
Radiological changes are an important part of diagnosing OA. Degree of radiological changes 
may be subtle in cases of mild to moderate disease, and might only be visible on MRIs at this 
initial stage (4). Radiologically glenohumeral OA is typically characterized by osteophyte 
formation, joint space narrowing, subchondral sclerosis and subchondral cyst formation. In 
OA, as opposed to for example rheumatoid arthritis, the joint space narrowing is 
predominantly posterior which results in eccentric posterior glenoid wear. Osteophyte 
formation is usually seen in proportion to the degree of joint space narrowing (6). 
1.1.2 Epidemiology and risk factors 
Musculoskeletal disorders in general have had and continue to have an immense impact on 
the population of the world (4). OA is as previously stated the most common form of arthritis 
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and OA in general is among the most common causes of severe pain and invalidity with 
studies indicating more than half of the adult population showing signs of the disease. In a 
study conducted by Garstang and Stitik 78% of persons aged 70 years and older were reported 
having symptomatic arthritis (7). At the time prevalence of OA was expected to increase by 
50% by the year 2020 (1;7). According a Canadian study from 2019 OA affects 9.6% of men 
and 18.0% of women over 60 years of age worldwide (8). OA of the glenohumeral joint, 
however, is considered rare and far from as common as osteoarthritis of the larger weight-
bearing joints, such as the hip and the knee. However, a study from 2011 found a 16,1% 
prevalence among the elderly population of South Korea (9).  
Risk factors for developing OA include age, genetics, sex, weight, joint infection, history of 
shoulder dislocation and previous injury. The prevalence of OA increases with age and nearly 
60% of those affected are older than 65 years. Additionally, people with certain occupations 
that require a heavy work load or overhead work have increased risk of later developing OA 
in the shoulder joint (4).  
1.1.3 Treatment  
Treatment of OA depends on the severity of symptoms; degree of pain, work restriction and 
activity level. The main aim of treatment is pain relief and regaining a satisfactory range of 
motion for the patient to be able to resume “pre-OA” daily function (2). 
Conservative treatment includes the use of NSAIDs/analgesics, physical therapy and steroid 
injections (10). At the moment there are no documented treatment options that reverse the 
disease and therefore aims become to relieve pain and restore function. Mild degenerative 
disease can be treated with physical therapy and medication. More advanced cases that prove 
refractory to these treatment options can be managed by corticosteroid injections. Surgery is 
indicated in severe cases where other treatment options have failed (4). 
1.2 Shoulder arthroplasty  
The first documented shoulder arthroplasty dates back to 1891, and Neer published his 
historical indications for total shoulder arthroplasty (TSA) in the 1970’s. Following this the 
debate about indications for TSA and HSA, stemmed or stemless, kicked off and is still going 
(11). Pfahler et al. stated in 2006 that most studies at the time reported better results of the 
TSA than those of the HSA, however risk of complications need to be taken into 
consideration (12). What keeps the debate going is the hypothesis that stemless designs are 
more adaptive to premorbid patient anatomy and cause fewer complications by preserving 
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bone stock and making for easier revisions (13). Concerning hemiarthroplasty of the shoulder 
more results including stemless alternatives are needed to assess the functionality and 
durability of these compared to TSA (14). 
1.2.1 Arthroplasty choices 
Meticulous clinical judgement is needed to select the appropriate prosthesis as there are 
several different approaches to arthroplasty surgery. The options include humeral head 
resurfacing (i.e. stemless hemiarthroplasty), stemmed hemiarthroplasty, anatomical total 
shoulder arthroplasty and reverse total shoulder arthroplasty. For the glenoid, options include 
leaving as is, using implants or non-implants resurfacing (11). The gold standard for surgical 
treatment of glenohumeral OA is conventional total shoulder arthroplasty with stemmed 
implants and documentation shows sufficient results related to pain reduction and regain of 
shoulder function (14).  
1.2.2 Complications 
Complications of shoulder arthroplasty include bone stock loss, intraoperative and 
postoperative periprosthetic fractures, rotator cuff deficiency, neural damage, glenoid erosion, 
mal-positioning of the humeral component and occasionally infections affecting the 
medullary canal, which can be difficult to eradicate. The main complication of shoulder 
arthroplasty is loosening of the implants (11;14).  
Stem-related complication, along with the possibility of easier revisions and preservation of 
bone-stock lead to the introduction of stemless or short-stemmed humeral implants (15). This 
resulted in the first stemless alternative to humeral implants becoming available in Europe in 
2004. There have been several studies showing promising results on short- to midterm follow 
up on stemless TSA, and in 2018 Beck et al. published one of the first studies on long term 
follow up on these kinds of shoulder replacement procedures (16). Stemless alternatives are 
being increasingly used but mid- and long term results, though firstly on total shoulder 
replacements (14).  
1.3 Aims 
The purpose of this thesis is to assess patient satisfaction, functional and radiological 
outcomes of stemless hemiarthroplasty with a single implant type on patients with 
glenohumeral OA operated at UNN from 2010 to 2016. Our hypothesis was that stemless 
hemiarthroplasty is a good and reliable alternative for treatment of shoulder OA. 
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2 Materials and methods 
2.1 Study design and material  
Since 2010 about 60-70 stemless hemiarthroplasty of the shoulder was performed at the 
Orthopedic department at the University Hospital of North Norway. 35 patients underwent 
surgery with OA as indication. Other indications were proximal humeral fractures and rotator 
cuff arthropathy. Inclusion criteria for this study were patients with glenohumeral 
osteoarthritis operated with stemless HSA using the Eclipse prosthesis (Arthrex, Naples, 
USA) between 2010 and 2016. Exclusion criteria include patients with severe organ failure, 
malignancy, reduced general state of health and revision surgery.  
35 patients were invited to participate in the study. 14 patients were lost to follow up and 
among these, six declined participation, three died, two were excluded because of 
comorbidity and four underwent revision surgery because of rotator cuff tear. All in all, 21 
shoulders belonging to 17 unique patients were assessed.  
The follow up period was between four and eleven years. The evaluation includes both 
clinical and radiological outcome. Patients were also asked to report their actual pain levels 
(i.e. pain at the time of follow up). Furthermore, we included a single categorical question 
evaluating patient satisfaction, asking if they were satisfied having had the surgery (answer 
either ‘yes’ or ‘no’).  
2.2 Clinical assessment 
The clinical evaluation was conducted pre- and postoperatively using two shoulder scores, 
ASES and the Constant-Murley score, in addition Visual Analog Scale (VAS-score) was used 
to determine pain levels both pre- and postoperatively. A vast number of tools to help assess 
functionality and clinical outcomes of shoulder pathology and surgeries exist. Both CS and 
ASES are among those widely acknowledged in the scientific community, both scores have 
psychometric properties that make them acceptable for evaluation of glenohumeral OA (17). 
Few scoring systems are gold standards due to varying limitations and psychometric 
properties, however according to a review article by Angst et al. assessing different 
measurement methods of shoulder function ASES and CS are highly accepted in the clinical 
community for osteoarthritis and arthroplasty respectively (17). ASES consists of a patient-
rated and a physician-rated part, but does not include physical examination and can be used 
for self-assessment by the patient. The maximum score is 100, and the final sum is 50% pain 
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and 50% function. The higher the score the better (17;18). The CS was first used in 1987, and 
though not validated at the time it was published several studies have later validated its use 
after, among other indications, shoulderarthroplasty. Though not strictly validated for many 
shoulder related conditions the book “The shoulder” reports it as the most used outcome score 
in the literature (11). The CS consists of four parts; pain level, ADL, mobility and strength. 
Pain and ADL are assessed by interview (35 points) and mobility and strength by physical 
examination (65 points). The maximum score is 100. The strength and mobility being such a 
considerable part of the final score might be of benefit when assessing shoulder arthritis (18).  
2.3 Radiological assessment  
Radiographs in anterior-posterior and axillary plane were used to assess radiological changes. 
Evaluation of possible radiological changes were divided into three categories; radiolucent 
lines surrounding HSA-implant, migration of caput humeri, measured by difference in 
acromiohumeral distance (mm) from post-op control to last follow up; no migration = 0 mm, 
slight migration = 0.1-5.0 mm, moderate migration = 5.1-7.0 mm, severe migration >7.0 mm, 
and to what degree glenoid osteoarthritis occurred. Glenoid OA is measured on a numeric 
scale with 0 indicating no glenoid OA, 1 indicating low degree, 2 indicating moderate degree 
and 3 indicating high degree of OA. All patients except one presented with radiographs taken 
ahead of the clinical evaluation.  
2.4 Statistics 
Descriptive statistics are presented in table as median with range and SD in parentheses for 
continuous variables. The Shapiro-Wilks test was used to determine normality for all 
variables. Wilcoxon Signed Rank test was used to compare the pre- and post-operative means 
as most of the variables were tested as non-normal. A two-tailed p-value of <0.05 was 
considered significant. To analyze correlation between functional outcome and radiological 
changes Spearman’s correlation was used. IBM SPSS 27.0 was used for statistical analyses.  
2.5 Ethical considerations 
Prior to collecting the study data through clinical sessions at UNN the study was approved by 
REK (“Regionale komiteer for medisinsk og helsefaglig forskningsetikk), case number REK 
Nord Ref 142110 (see enclosure 1 for full sanction). 
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2.6 Work process  
The process of this thesis started in March/April 2020 when my supervisor presented this 
project and I agreed to take it on. I used a month from March to April writing the protocol 
with help from my supervisor. During the fall semester of 2020 we planned and carried out 
three days of clinical evaluation where patients had taken radiographs ahead of their 
appointment and were clinically and radiologically assessed by my supervisor and myself. 
The main part of the writing process and statistical analyses was conducted during spring 
2021, after I had finished my clinical rotations on my fifth year.  
3 Results 
35 patients eligible for this study received stemless HSA during a time period of seven years. 
21 shoulders in 17 patients were available for last follow up. Four patients had undergone 
bilateral stemless hemiarthroplasty with an interval of one to three years between operations. 
Three patients (four shoulders) were assessed through a telephone interview as they lived far 
away and did not wish to make the journey to Tromsø. One of these patients did not present 
with any radiographs and was unable to be evaluated radiologically. 
Mean follow up time for this study was 7,2 years (range 4 to 11, SD ± 1,9) and mean age of 
patients at the time of follow up was 69,5 years (range 50 to 85, SD ± 8,9) (table 1).  
 
Table 1 Descriptive data 
Variable n Mean (SD) Range 
Years since surgery 21 7.19 (1.9) 7 (4-11) 
Age at follow up 21 69.57 (8.9) 35 (50-85) 
VAS pre 21 7.52 (0.87) 3 (6-9) 
VAS post 21 1.81 (2.87) 10 (0-10) 
CS pre 21 33.48 (8.36) 34 (20-54) 
CS post 21 79.57 (18.3) 67 (31-98) 
ASES pre 20 36.40 (7.27) 32 (20-52) 
ASES post  21 84.10 (23.7) 87 (13-100) 
• SD: standard deviation 
• Range: difference (interval)  
 
95,2% (n=20) of the patients stated they were satisfied with the decision of having surgery. 
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3.1 Functional outcomes 
Comparing data from pre-operation to post-operation the VAS-score improved from 7.5 ± 0.9 
to 1.8 ± 2.9 (p<0.05). The ASES score improved significantly 36.4 ± 7.2 to 84.10 ± 23.7 
(p<0.05), as did the Constant-Murley score from 33.5 ± 8.4 to 79.6 ± 18.0 (p<0.05). The 
Wilcoxon signed-ranks test thus showed statistically significant improvement in all three 
matched pairs (pre- and post-op) measuring functional outcome. Functional outcome means 
and SD are presented in Table 2.  
 
Table 2 Pre- and postoperative values of stemless HSA  
Variable Maximum 
Pre-operative 
mean ± SD 
Post-operative 
mean ± SD 
p-value* 
VAS 10 7.5 ± 0.9  1.8 ± 2.9 < 0.05 
Constant-
Murley 
100 33.5 ± 8.4  79.6 ± 18.0 < 0.05 
ASES 100 36.4 ± 7.2 84.10 ± 23.7 <0.05 
*analysed using Wilcoxon signed-rank test 
 
3.2 Radiological outcomes  
20 shoulders were available for radiographic follow up. 20% (n=4) had no superior migration 
and 70% (n=14) showed slight superior displacement (range 0.1-5.0 mm). Moderate superior 
displacement of the humeral head was found in 10% (n=2) with a maximum migration of 5.3 
mm. No severe migration was observed.  
Radiolucent lines along the bone implant interface was observed in (n=3). For glenoid OA the 
mean was 1.3 ± 1.2. 35% of the patients (n=7) had low degree, 10% (n=2) had moderate 
degree and 25% (n=5) had high degree of OA on the glenoid surface. Radiological outcomes 





Fig 1: Anteroposterior radiographs. Preoperative (A) and at last follow up 8 years after 
surgery (B). This patient had an improvement in ASES from 22 to 89, and in CS from 36 to 
100, and VAS 0 at follow up. No caput migration, glenoid OA or radiolucency was observed.  
 
3.2.1 Influence of radiological changes on functionality and pain 
To determine correlation between clinical variables and radiological changes a Spearman 
correlation test was used. There was no statistically significant correlation between 
radiological degree of OA or radiolucency and postoperative VAS, ASES or CS. There was a 
moderate, positive correlation between postop VAS and caput migration (Spearmans’ rho = 













Tabell 3 Radiological outcomes at follow up 










Degree of glenoid OA  mean ± SD 
1.3 ± 1.2 
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The most important finding in this study of patients with shoulder joint OA is that at last 
follow up time there was still a significant improvement in the VAS, ASES and CS. The 
development of glenoid OA was only observed in five patients (25%) without influencing the 
clinical outcomes. As briefly mentioned the stemmed TSA has long been regarded as the gold 
standard of shoulder arthroplasty, but since the introduction of stemless alternatives in 2004 
several short- to midterm studies on stemless humeral implants have been published. 
However, mid- to long term results are scarce. Technological progression is still being made, 
and fourth generation humeral implants are considered better than its forerunners, focusing on 
preventing stem-related complications such as bone loss and making revision easier (16;19).  
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Habermeyer et al. published the first midterm results on a stemless TSA in 2015. 78 patients 
were followed for a mean period of 72 months. 14 patients with OA were operated with HSA 
and 25 with TSA, using the Eclipse prosthesis. Both groups had significant improvement in 
CS and pain relief, and no significant difference in CS was observed between the 
hemiarthroplasty group when compared to total shoulder arthroplasty (20). In another study; 
Hawi et al. reported nine year outcomes after stemless arthroplasty, comparing TSA and 
HSA. The authors found significant improvement of CS in both groups and no significant 
difference between the HSA group and the TSA group (21). This is in line with the finding of 
this study presenting significant outcomes using stemless HSA. In another study, Brunner et 
al. reported a significant improvement in CS score for patients operated with the Eclipse 
prosthesis, both as HSA and TSA, after a two year follow period. The authors stated that 
patients with shoulder OA benefitted from the stemless arthroplasty, both HSA and TSA 
improved significantly, however the TSA group showed greater improvement in pain levels 
and functionality (22). 
 
A recent study published in march 2021 by Singh et al. addresses stemless shoulder 
arthroplasty, and functional and radiological outcomes of stemless TSA using the Eclipse 
prosthesis (19). This study follows 30 elderly patients from India with primary osteoarthritis 
for a short and midterm evaluation where preoperative CS and ASES improved from 
respectively 27.3 and 29.7 to 68 and 71.4 respectively. Functional scores are compared to our 
study lower both pre- and postoperatively, though the improvement is comparable to ours. 
Similar to our study where we found no gross complications; Singh et al. mention no specific 
complication rates. These low scores might be a consequence of patients seeking surgical 
intervention at a later stage than in western countries (19). Maier et al. conducted a study 
comparing outcomes between stemless and stemmed TSA for glenohumeral OA in 2015. In 
this study 12 patients were operated with the TESS implant, a stemless alternative TSA, and a 
control group with comparable demographics received a standard stemmed TSA. This was a 
short-term follow up, however they found no statistically significant differences in either 
postoperative proprioception or CS between the two groups (14).  
In the present study, there was no loosening of any prosthesis and there was a relatively low 
rate of radiolucency around the humeral implant. Additionally, we did not find significant 
correlation between radiolucency nor OA of glenoid and functional outcomes, as well as pain 
levels. None of our patients were considered for revision based on this mild to moderate 
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degree of radiolucency. This indicates decent survival rates of the Eclipse HSA in mid- to 
long-term perspective. Beck et al. and Heuberer et al. agrees that radiolucent lines are not 
uncommon and may appear postoperatively without it being an isolated indication for 
revision surgery (16;23). These finding are also in line with the present study of stemless 
HSA. The present study reveals outcome results with significant improvement on all 
variables, a strength considering the shortage of articles on mid- to long-term perspective on 
stemless HSA. The clinical relevance of the present study is that stemless HSA is a simple, 
safe and reliable method for treating shoulder OA. 
4.1 Strengths and limitations  
In the present study, the treatment options were not mixed and one group received only 
stemless HSA, making the results more coherent. The length of follow up and specific 
indication (glenohumeral OA) should be considered a strength as there are few studies on 
hemiarthroplasty evaluating this problem specifically. In addition, the fact that both clinical 
and radiological outcomes are studied. No severe complications reported is another strength. 
The limitations of the study include the relatively small number of participants as well as the 
lack of control group. Furthermore, four shoulders were evaluated using telephone interview 
and may affect the grading of ASES and CS. A further weakness is that it lacks a second 
reviewer for radiological evaluation and has not undergone a test-retest procedure. For future 
studies, a larger cohort is recommended.   
5 Conclusion 
The present study reveals predictably better function with the stemless hemiarthroplasty at 
midterm follow up. We found statistically significant improvement in VAS, ASES and CS 
from pre-operative to post-operative evaluation. Radiological findings had low correlation 
rate with functional outcomes, particularly radiolucency and glenoid OA. 95% (n=20) of the 
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